Matches in DBpedia 2014 for { ?s ?p Muraglitazar (proposed tradename Pargluva) is a peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ.The drug had completed phase III clinical trials, however in May, 2006 Bristol-Myers Squibb announced that it had discontinued further development.Data on muraglitazar is relatively less due to the recent introduction of this agent.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Muraglitazar comment "Muraglitazar (proposed tradename Pargluva) is a peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ.The drug had completed phase III clinical trials, however in May, 2006 Bristol-Myers Squibb announced that it had discontinued further development.Data on muraglitazar is relatively less due to the recent introduction of this agent.".